1. Introduction
===============

In recent years, soft corals have become one of the most prolific sources for the discovery of novel secondary metabolites \[[@B1-marinedrugs-12-04495],[@B2-marinedrugs-12-04495]\]. A variety of sesquiterpenes related to eremophilane- and neolemnane-types, and others have been reported from the Taiwanese soft corals of the genera *Lemnalia* and *Paralemnalia* \[[@B3-marinedrugs-12-04495],[@B4-marinedrugs-12-04495],[@B5-marinedrugs-12-04495],[@B6-marinedrugs-12-04495],[@B7-marinedrugs-12-04495],[@B8-marinedrugs-12-04495],[@B9-marinedrugs-12-04495],[@B10-marinedrugs-12-04495]\]. Our recent study of the chemical constituents of the Lanyu soft coral *L. philippinensis* has yielded ylangene-type sesquiterpenoids, philippinlins A and B \[[@B11-marinedrugs-12-04495]\]. Our continuing investigation of the same collection of this organism again led to the isolation of two new eremophilane-type and one new neolemnane-derived sesquiterpenoids, philippinlins C--E (**1**--**3**), along with two known compounds, 11,12-dihydroxy-6,10-eremophiladiene (**4**) and 4-acetoxy-10-hydroxy-5-oxo-2,8-neolemnadiene (**5**) ([Chart 1](#marinedrugs-12-04495-f004){ref-type="fig"}). The structures of **1**--**5** were elucidated on the basis of extensive spectroscopic analyses and by comparison of the spectral data with those of the related metabolites. The cytotoxicity of metabolites **1**--**5** towards human liver carcinoma (HepG2), human breast carcinoma (MDA-MB231) and human lung adenocarcinoma epithelial cells (A549) was evaluated; however, none of these compounds was shown to exhibit cytotoxicity towards these cancer cell lines in the present study.

![Structures of metabolites **1**--**5**.](marinedrugs-12-04495-g004){#marinedrugs-12-04495-f004}

2. Results and Discussion
=========================

Freshly collected soft coral was immediately cooled to −20 °C and kept frozen until extraction. The animal material was extracted exhaustively with EtOAc. The EtOAc extract was fractionated by silica gel column chromatography and the eluted fractions were further separated utilizing normal phase HPLC to afford three new sesquiterpenes (**1**--**3**) together with two known related sesquiterpenes (**4** and **5**). The known sesquiterpenes were readily identified as 11,12-dihydroxy-6,10-eremophiladiene (**4**) \[[@B4-marinedrugs-12-04495],[@B5-marinedrugs-12-04495],[@B12-marinedrugs-12-04495]\] and 4-acetoxy-10-hydroxy-5-oxo-2,8-neolemnadiene (**5**) \[[@B4-marinedrugs-12-04495],[@B5-marinedrugs-12-04495]\], by comparison of their spectral data with those reported in the literatures.

Philippinlin C (**1**) was obtained as a colorless oil. Its molecular formula was determined as C~15~H~22~O~3~ on the basis of HR-ESI-MS (*m/z* 273.1465, \[M + Na\]^+^), indicating five degrees of unsaturation. IR absorptions was observed at 3420 cm^−1^, suggesting the presence of hydroxy group in **1**. The ^13^C NMR and DEPT spectroscopic data ([Table 1](#marinedrugs-12-04495-t001){ref-type="table"}) of **1** revealed the presence of three methyls, four sp^3^ methylenes (including one oxygenated resonating at δ~C~ 68.3), one sp^3^ methine, two sp^2^ methines and five quaternary carbons (including one oxygenated carbons at δ 74.9, two olefinic carbons with resonances at δ 139.4 and 170.1 and one carbonyl carbon δ 199.1). From the required five degrees of unsaturation and the three double bonds known from the above data, a bicyclic sesquiterpene framework of **1** was deduced. The ^1^H NMR data revealed the presence of two olefinic methine protons as one singlet at δ 5.83 and one doublet at δ 5.89, respectively. Furthermore, one oxygenated methylene group (δ 3.62, d, *J* = 11 Hz; δ 3.44, d, *J* = 11.0 Hz) was also designated from the ^1^H NMR signals. The planar structure and all of the ^1^H and ^13^C chemical shifts of **1** were elucidated by 2D NMR spectroscopic analysis, in particular COSY and HMBC experiments ([Figure 1](#marinedrugs-12-04495-f001){ref-type="fig"}). The COSY correlations of H-4 with both H~2~-3 and H~3~-15, and H~2~-8 with H~2~-9 allowed the establishment of two partial structures. The following key HMBC correlations permitted connection of the carbon skeleton: H-1 to C-3 and C-5; H-3 to C-2; H-6 to C-5, C-8, C-10 and C-11; H~2~-9 to C-1, C-5, C-7 and C-10; H~2~-12 to H-7; H~3~-13 to C-7, C-11 and C-12; H~3~-14 to C-4, C-5 and C-6 and H~3~-15 to C-3, C-4 and C-5. Thus, **1** was found to possess two hydroxy groups at C-11 and C-12, two double bonds at C-1/C-10 and C-6/C-7, three methyls at C-4, C-5 and C-11, and a ketone group at C-2. Furthermore, by comparison of the NMR data of **1** with those of **4**, it was found that the ^1^H and ^13^C NMR data of **1** are similar to those of **4**, except the replacement of the CH~2~ in **4** by a ketone group (C=O) in 1. The relative configurations of the two chiral centers at C-4 and C-5 in **1** were elucidated by the following NOE analysis. It was found that H~3~-14 showed NOE interactions with H~3~-15. Thus, assuming the β-orientation of H~3~-14, H~3~-15 should also be positioned on the β face. Based on the above results, the structure of **1** was mostly established. However, the relative configuration of a stereogenic center at C-11 can not be assigned at present stage.

The HR-ESI-MS spectrum of philippinlin D (**2**) exhibited a molecular ion peak at *m/z* 275.1622 (\[M + Na\]^+^), consistent with the molecular formula C~15~H~24~O~3~. Comparison of the NMR data ([Table 1](#marinedrugs-12-04495-t001){ref-type="table"}) of **2** with that of **1** revealed that the structures of both compounds are similar, with the difference that the ketocarbonyl carbon (C-2) of **1** was replaced by a hydroxy group-bearing methine carbon of **2**. Thus, in the ^13^C NMR spectrum of **1** the signal at δc 199.1 was replaced by a signal at δc 64.1, and in the ^1^H NMR spectrum of **2** the signal at δ~H~ 4.10 (brs) could be attributed to a hydroxyl-bearing methine at C-2. The α-orientation of 2-hydroxy group was determined by comparison of the *J*~1,2~ of **2** with those of elongatols A--B \[[@B13-marinedrugs-12-04495]\], aromatin D and its 2-epimer \[[@B14-marinedrugs-12-04495]\]. Therefore, metabolite **2** was identified as the α-hydroxy derivative at C-2 of the known compound **4**. Still, we are unable to determine the relative configuration of the chiral center C-11 at this time.
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###### 

^13^C and ^1^H NMR spectral data for compounds **1**, **2** and **3**.

  1                           2               3                                                                            
  --------------------------- --------------- --------------------------- -------------- ------------------ -------------- ---------------------
  **Position**                **δ~C~**        **δ~H~**                    **δ~C~**       **δ~H~**           **δ~C~**       **δ~H~**
  **Multiplicity**            ***J*in Hz**    **Multiplicity**            ***J*in Hz**   **Multiplicity**   ***J*in Hz**   
  1                           124.2 (CH)      5.83 s                      121.4 (CH)     5.54 d (4.0)       124.6 (CH)     5.69 d (10.0)
  2                           199.1 (C)                                   64.1 (CH)      4.10 br s          132.0 (CH)     5.97 d (10.0, 4.0)
  3                           42.6 (CH~2~)    2.34 m                      36.6 (CH~2~)   1.73 m; 1.65 m     31.0 (CH~2~)   2.08 dt (19.0, 4.0)
  1.80 dd (19.0, 11.5)                                                                                                     
  4                           38.3 (CH)       2.05 m                      32.1 (CH)      1.71 m             34.2 (CH)      2.16 m
  5                           39.9 (C)                                    38.6 (C)                          40.4 (C)       
  6                           127.5 (CH)                                  129.1 (CH)     5.88 s             148.3 (CH)     6.30 s
  7                           139.4 (C)                                   138.3 (C)                         126.0 (C)      
  8                           26.5 (CH~2~)    2.35 m; 2.12 m              27.5 (CH~2~)   2.22 m; 2.02 m     164.6 (C)      
  9                           30.7 (CH~2~)    2.57 ddd (13.0, 6.5, 1.5)   29.7 (CH~2~)   2.40 m;            177.1 (C)      
  2.44 ddd (13.0, 5.0, 1.5)   2.20 m                                                                                       
  10                          170.1 (C)                                   147.7 (C)                         27.7 (CH~2~)   2.60 m; 2.54 m
  11                          74.9 (C)                                    75.0 (C)                          28.9 (CH~2~)   2.45 m; 1.73 m
  12                          68.3 (CH~2~)    3.62 d (11.0);              68.4 (CH~2~)   3.60 d (11.0);     83.4 (C)       
  3.44 d (11.0)               3.40 d (11.0)                                                                                
  13                          23.8 (CH~3~)    1.31 s                      23.7 (CH~3~)   1.28 s             16.8 (CH~3~)   1.93 s
  14                          19.4 (CH~3~)    1.15 s                      19.4 (CH~3~)   0.94 s             13.7 (CH~3~)   0.95 s
  15                          15.2 (CH~3~)    1.06 d (6.5)                15.3 (CH~3~)   0.99 d (6.0)       15.1 (CH~3~)   0.92 d (6.5)

Spectra recorded at 125 MHz in CDCl~3~ for ^13^C NMR and 500 MHz in CDCl~3~ for ^1^H NMR~.~

![Selected COSY (▬) and HMBC (→) correlations of **1** and **3**.](marinedrugs-12-04495-g001){#marinedrugs-12-04495-f001}

Philippinlin E (**3**) was obtained as a white powder. The molecular formula was determined to be C~15~H~20~O~4~, as deduced from its HR-ESI-MS (*m/z* 287.1257, \[M + Na\]^+^) and ^13^C NMR data ([Table 1](#marinedrugs-12-04495-t001){ref-type="table"}). A broad IR absorption at 3402 cm^−1^ indicated the presence of a hydroxy group. The NMR data ([Table 1](#marinedrugs-12-04495-t001){ref-type="table"}) showed resonances for one trisubstituted double bond (δ~H~ 6.30, s; δ~C~ 148.3 (CH), 126.0 (C)), one 1,1-disubstituted double bond (δ~H~ 5.97 (dd, *J* = 10.0, 4.0 Hz) and δ~H~ 5.69 (d, *J* = 10.0 Hz); δ~C~ 124.6 (CH) and δ~C~ 132.0 (CH)) and two carbonyl carbons (δ~C~ 177.1 and δ~C~ 164.6). To satisfy the six degrees of unsaturation and take into account the presence of two olefinic double bonds and two carbonyl groups, it was assumed that **3** possesses a bicyclic structure. From the COSY spectrum ([Figure 1](#marinedrugs-12-04495-f001){ref-type="fig"}), the partial structures of a proton spin system extending from H-1 to H~3~-15 through H-4 and from H~2~-10 to H~2~-11 could be established, assigning a secondary methyl group at C-4. The molecular framework of **3** was further established by correlations of an HMBC experiment ([Figure 1](#marinedrugs-12-04495-f001){ref-type="fig"}). The two rings and their connectivities to other substituents were elucidated on the basis of the following key HMBC correlations: H~3~-15 to C-3, C-4 and C-5; H~3~-14 to C-4, C-5, C-6 and C-12; H~3~-13 to C-6, C-7 and C-8; H~2~-11 to C-1, C-5, C-9 and C-12; H-1 to C-5 and C-12; H-4 to C-5 and C-12; H-6 to C-5, C-8 and C-12 and H-10 to C-12. Thus, this compound was found to possess two double bonds at C-1/C-2 and C-6/C-7, and two carboxyl groups at C-8 and C-9. Connection of all the above functional groups could lead to the planar structure **3** or an isomeric form 6 ([Chart 2](#marinedrugs-12-04495-f005){ref-type="fig"}). For form **6**, an α,β-unsaturated carboxylic acid and a γ-lacton ring should show IR absorptions at about 1690--1710 and 1760--1770 cm^−1^, respectively. However, compound **3** exhibited carbonyl absorption at 1714 cm^−1^ only. Furthermore, 3 was found to have very similar NMR and IR spectroscopic data for the α,β-unsaturated ester moiety in comparison with those of **7** ([Chart 2](#marinedrugs-12-04495-f005){ref-type="fig"}), which has been prepared previously by a stereospecific synthesis \[[@B15-marinedrugs-12-04495]\]. The relative stereochemistry was also confirmed by analysis of the NOESY spectrum ([Figure 2](#marinedrugs-12-04495-f002){ref-type="fig"}). H~3~-14 showed NOE with both H~2~-11 and H~3~-15 but not with H-4. Thus, assuming a β-orientation of H~3~-14, both H~2~-11 and H~3~-15 should be placed on the β face. On the basis of above analysis, the structure of **3** was established.

![Planar structure of Formula **6** and structure of **7**.](marinedrugs-12-04495-g005){#marinedrugs-12-04495-f005}

![Key NOESY correlations for **3**.](marinedrugs-12-04495-g002){#marinedrugs-12-04495-f002}

The skeleton of **3** is new as a natural product, however, **3** has been found previously by treatment of a neolemnane-type compound, 4(*S*\*)-acetoxy,10(*S*\*)-hydroxy,5-oxo,1(*S*\*),12(*S*\*)neolemna-2(*Z*),8-diene, with a methanolic Na~2~CO~3~ solution in air to give an intermediate which should be the unpurified **3**. This unpurified acid was further reacted with diazomethane to give the methyl ester of acid **3** \[[@B4-marinedrugs-12-04495]\]. We are the first group to isolate and characterize **3** from natural sources. Compound **3** might be a natural product, or an artifact from the oxidation of a related neolemane precursor.

A plausible biosynthetic pathway of **3** was postulated as shown in [Scheme 1](#marinedrugs-12-04495-f003){ref-type="scheme"}. This pathway involves oxidation with ring cleavage of a neolemnane precursor and the subsequent nucleophilic conjugate substitution to afford **3**. The cytotoxicity of metabolites **1**--**5** against the growth of HepG2, MDA-MB231 and A549 carcinoma cells was studied. The results showed that **1**--**5** are not cytotoxic (IC~50~ \> 20 μg/mL) toward the above cancer cells. We suggest that further investigation of other bioactivities of these metabolites should be carried out in the future.

![Proposed biosynthetic pathway for **3**.](marinedrugs-12-04495-g003){#marinedrugs-12-04495-f003}

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Optical rotation values were measured with a Jasco-P1010 digital polarimeter. Infrared spectra were obtained on a Varian Diglab FTS 1000 FT-IR spectrophotometer. NMR spectra were recorded on a Varian Unity INOVA 500 FT-NMR at 500 MHz for ^1^H and 125 MHz for^13C\ or\ on\ a\ Varian\ 400\ MR\ FT-NMR\ at\ 400\ MHz\ for\ 1^H and 100 MHz for ^13^C in CDCl~3~ at 25 °C. ESIMS and HRESIMS data were recorded on a Bruker APEX II mass spectrometer. Column chromatography was performed on silica gel (230--400 mesh, Merck, Darmstadt, Germany). TLC was carried out on precoated Kieselgel 60 F~254~ (0.25 mm, Merck, Darmstadt, Germany) and spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating. Normal phase HPLC (NP-HPLC) was performed using a system comprised of a Hitachi L-7110 pump, a Hitachi L-7455 photodiode array detector and a Rheodyne 7725 injection port. A normal phase column (Supelco Ascentis^®^ Si Cat \#:581515-U, 25 cm × 21.2 mm, 5 μm) was used for NP-HPLC. Reverse phase HPLC (RP-HPLC) was performed using a system comprised of a Hitachi L-7100 pump, a Hitachi L-2455 photodiode array detector and a Rheodyne 7725 injection port. A reverse phase column (Varian Polaris C18-A, 250 mm × 10 mm, 5 μm) was used for RP-HPLC.

3.2. Animal Material
--------------------

*L. philippinensis*, taxonomically identified by Chang-Feng Dai of National Taiwan University, was collected by hand using scuba off the coast of Lanyu, Taiwan, in August 2008, at a depth of 10--15 m, and stored in a freezer until extraction. A voucher sample was deposited at the Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Taiwan.

3.3. Extraction and Isolation
-----------------------------

Sliced bodies of the soft coral *L. philippinensis* (0.8 kg, wet wt) were exhaustively extracted with ethyl acetate (EtOAc). The EtOAc extract was evaporated to yield a residue (10.7 g) which was subjected to column chromatography on silica gel by stepwise elution with *n*-hexane-EtOAc mixture and EtOAc-MeOH mixture, to give 25 fractions. Fraction 17, eluting with *n*-hexane--EtOAc (2:1), was further separated by silica gel open column with gradient elution (*n*-hexane--EtOAc, 13:2) to yield 5 subfractions (17A--E). Subfraction 17E was separated by normal phase HPLC using *n*-hexane--EtOAc(2:3) as the mobile phase to afford **1** (1.1 mg), **2** (2.7 mg) and **4** (1.0 mg). Both fractions 18 and 19, eluting with *n*-hexane--EtOAc (1:1--1:2), were combined and further separated by column chromatography over silica gel with gradient elution (*n*-hexane--EtOAc, 7:2) to yield 8 subfractions (18A--H). Subfraction 18D was separated by normal phase HPLC (*n*-hexane--EtOAc, 7:2) to afford **5** (3.5 mg). Subfraction 18G was separated by normal phase HPLC with the elution of *n*-hexane--EtOAc (2:1) to afford **3** (1.9 mg).

Philippinlin C (**1**): colorless oil; \[α\]^25^~D~ = −175 (*c* 0.1, CHCl~3~); IR (neat) ν~max~ 3420, 2923, 1652 and 1456 cm^−1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-12-04495-t001){ref-type="table"}; ESIMS *m*/*z* 273 \[M + Na\]^+^; HRESIMS *m*/*z* 273.1465 (calcd. for C~15~H~22~O~3~Na, 273.1467) ([Supplementary Information, Figures S1 and S2](#marinedrugs-12-04495-s001){ref-type="supplementary-material"}).

Philippinlin D (**2**): colorless oil; \[α\]^25^~D~ = −234 (*c* 0.1, CHCl~3~); IR (neat) ν~max~ 3384, 2922, 2857 and 1373 cm^−1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-12-04495-t001){ref-type="table"}; ESIMS *m*/*z* 275 \[M + Na\]^+^; HRESIMS *m*/*z* 275.1622 (calcd. for C~15~H~24~O~3~Na, 275.1623) ([Supplementary Information, Figures S3 and S4](#marinedrugs-12-04495-s001){ref-type="supplementary-material"}).

Philippinlin E (**3**): white powder; mp 124 °C; \[α\]^25^~D~ = −134 (*c* 0.2, CHCl~3~); IR (neat) ν~max~ 3402, 2940, 1714 and 1371 cm^−1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-12-04495-t001){ref-type="table"}; ESIMS *m*/*z* 287 \[M + Na\]^+^; HRESIMS *m*/*z* 287.1257 (calcd. for C~15~H~20~O~4~Na, 287.1259) ([Supplementary Information, Figures S5 and S6](#marinedrugs-12-04495-s001){ref-type="supplementary-material"}).

3.4. Cytotoxicity Testing
-------------------------

Cell lines were purchased from the American Type Culture Collection (ATCC). Cytotoxicity assays of compounds **1**--**5** were performed using the MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide\] colorimetric method \[[@B16-marinedrugs-12-04495],[@B17-marinedrugs-12-04495]\].

4. Conclusions
==============

Two new eremophilane-type compounds philippinlins C and D (**1** and **2**) a new 4,5-seconeolemnane philippinlin E (**3**), along with two known compounds, 11,12-dihydroxy-6,10-eremophilaiene (**4**) and 4-acetoxy-10-hydroxy-5-oxo-2,8-neolemnadiene (**5**), were discovered from the soft coral*L*. *philippinensis*. The molecular skeleton of **3** was discovered for the first time from natural sources.
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